{"id":2647,"date":"2018-05-16T23:42:07","date_gmt":"2018-05-16T18:12:07","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=2647"},"modified":"2025-05-12T15:00:45","modified_gmt":"2025-05-12T09:30:45","slug":"common-cold-cure","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/common-cold-cure","title":{"rendered":"Potential cure for Common cold"},"content":{"rendered":"<p style=\"background: white; text-align: justify;\"><span style=\"color: #333333;\">A group of Researchers at <a href=\"https:\/\/www.imperial.ac.uk\/\">Imperial College London<\/a> created a molecule that can successfully block multiple strains of the common cold\u00a0by targeting a protein required for the survival of the virus. The newly created molecule <strong>(IMP-1088<\/strong>) resides inside a protein in cells called <strong>N-myristoyltransferase<\/strong> (NMT). After invading the body, virus uses NMT to construct a shell for protecting their genomes, allowing them to replicate easily. Inhibiting the NMT with the molecule IMP-1088 restricted the growth and functioning of multiple strains of cold virus. According to the reports IMP-1088 has successfully blocked common cold virus without affecting the healthy cells. Team is planning to take IMP-1088 into animal trials to ensure that it is safe and does not target other conditions with different causes. Also, the team is now working on the drug delivery method via the lungs.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A group of Researchers at Imperial College London created a molecule that can successfully block multiple strains of the common cold\u00a0by targeting a protein required for the survival of the virus. The newly created molecule (IMP-1088) resides inside a protein in cells called N-myristoyltransferase (NMT). After invading the body, virus uses NMT to construct a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2725,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[41],"tags":[1631,1633,1342,204,1156,712,1632],"industry":[17225],"therapeutic_areas":[17231],"class_list":["post-2647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-snippets","tag-common-cold","tag-common-cold-virus","tag-consulting","tag-delveinsight","tag-pharma-consultant","tag-pharma-industry","tag-virus","industry-pharmaceutical","therapeutic_areas-infectious-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Potential cure for Common cold - DelveInsight Business Research<\/title>\n<meta name=\"description\" content=\"A group of Researchers at Imperial College London created a molecule that can successfully block multiple strains of the common cold\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/common-cold-cure\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Potential cure for Common cold - DelveInsight Business Research\" \/>\n<meta property=\"og:description\" content=\"A group of Researchers at Imperial College London created a molecule that can successfully block multiple strains of the common cold\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/common-cold-cure\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-16T18:12:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-12T09:30:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/05\/09021721\/cold-virus.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Potential cure for Common cold - DelveInsight Business Research","description":"A group of Researchers at Imperial College London created a molecule that can successfully block multiple strains of the common cold","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/common-cold-cure","og_locale":"en_US","og_type":"article","og_title":"Potential cure for Common cold - DelveInsight Business Research","og_description":"A group of Researchers at Imperial College London created a molecule that can successfully block multiple strains of the common cold","og_url":"https:\/\/www.delveinsight.com\/blog\/common-cold-cure","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2018-05-16T18:12:07+00:00","article_modified_time":"2025-05-12T09:30:45+00:00","og_image":[{"width":1000,"height":500,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/05\/09021721\/cold-virus.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/common-cold-cure","url":"https:\/\/www.delveinsight.com\/blog\/common-cold-cure","name":"Potential cure for Common cold - DelveInsight Business Research","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/common-cold-cure#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/common-cold-cure#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/05\/09021721\/cold-virus.jpg","datePublished":"2018-05-16T18:12:07+00:00","dateModified":"2025-05-12T09:30:45+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"A group of Researchers at Imperial College London created a molecule that can successfully block multiple strains of the common cold","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/common-cold-cure"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/common-cold-cure#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/05\/09021721\/cold-virus.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/05\/09021721\/cold-virus.jpg","width":1000,"height":500,"caption":"COMMON COLD"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/05\/09021721\/cold-virus-300x150.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">common cold<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">common cold virus<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">consulting<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">DelveInsight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">pharma consultant<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Pharma Industry<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">virus<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">common cold<\/span>","<span class=\"advgb-post-tax-term\">common cold virus<\/span>","<span class=\"advgb-post-tax-term\">consulting<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight<\/span>","<span class=\"advgb-post-tax-term\">pharma consultant<\/span>","<span class=\"advgb-post-tax-term\">Pharma Industry<\/span>","<span class=\"advgb-post-tax-term\">virus<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 8 years ago","modified":"Updated 12 months ago"},"absolute_dates":{"created":"Posted on May 16, 2018","modified":"Updated on May 12, 2025"},"absolute_dates_time":{"created":"Posted on May 16, 2018 11:42 pm","modified":"Updated on May 12, 2025 3:00 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/2647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=2647"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/2647\/revisions"}],"predecessor-version":[{"id":32074,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/2647\/revisions\/32074"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/2725"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=2647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=2647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=2647"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=2647"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=2647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}